ICIS Top Chemical Mergers & Acquisitions listing unveiled

NEW YORK and LONDON (ICIS)–ICIS Chemical Business magazine has unveiled its 2nd annual ICIS Top Chemical Mergers & Acquisitions (M&A) listing of the most important deals in the global chemical sector – changes in control that could impact supply chains.

In the 25 May issue of ICIS Chemical Business, all the notable chemical transactions completed in 2014 worldwide are covered. This year’s listing is sponsored by investment bank The Valence Group.

We break out deals by purchase price where disclosed, as well as by annual sales of the targets. Currencies are converted to US dollars based on exchange rates at the end of 2014.

Download the ICIS Top Chemical M&A listing (registration required).

“It’s been an active M&A market for chemicals. Cheap and available financing has fuelled deals for both private equity and strategic players,” said Joseph Chang, global editor of ICIS Chemical Business.

“The pace of activity has been high, but deals have tended to be on the smaller side, reflecting risk appetites,” he added.

But 2015 brings the prospect for larger multi-billion dollar deals. Some yet to close include Germany-based Merck KGaA’s planned $17bn acquisition of US-based Sigma-Aldrich, and US-based Olin’s merger with Dow Chemical’s global chlor-alkali and derivatives business in a $5bn Reverse Morris Trust (RMT) transaction.

On a geographic basis, buyer headquarters as well as the location of the target are tracked.

In the listing, core chemical sector deals are reflected, where possible. Thus we exclude fertilizers, industrial gases, seed businesses, energy and fuels, refining and midstream.

The goal is to bring you deals that are most relevant to buyers and sellers of chemicals, as well as analysts and senior executives.